• Mashup Score: 1
    Home - 4 day(s) ago

    Activity Overview

    Tweet Tweets with this article
    • 🫀 Learn how to assess residual CV risk in patients with dyslipidemia and explore the latest on CETP inhibition for LDL-C lowering and ASCVD risk reduction. 📍 https://t.co/A4kdNKvOoT #Cardiology #Dyslipidemia #HeartHealth https://t.co/RufGggiOmF

  • Mashup Score: 1
    Home - 5 day(s) ago

    Activity Overview

    Tweet Tweets with this article
    • 🫀 Learn how to assess residual CV risk in patients with dyslipidemia and explore the latest on CETP inhibition for LDL-C lowering and ASCVD risk reduction. 📍 https://t.co/A4kdNKvOoT #Cardiology #Dyslipidemia #HeartHealth https://t.co/RufGggiOmF

  • Mashup Score: 1
    Home - 8 day(s) ago

    Activity Overview

    Tweet Tweets with this article
    • 🫀 Learn how to assess residual CV risk in patients with dyslipidemia and explore the latest on CETP inhibition for LDL-C lowering and ASCVD risk reduction. 📍 https://t.co/A4kdNKvOoT #Cardiology #Dyslipidemia #HeartHealth https://t.co/RufGggiOmF

  • Mashup Score: 1
    Home - 10 day(s) ago

    Activity Overview

    Tweet Tweets with this article
    • 🫀 Learn how to assess residual CV risk in patients with dyslipidemia and explore the latest on CETP inhibition for LDL-C lowering and ASCVD risk reduction. 📍 https://t.co/A4kdNKvOoT #Cardiology #Dyslipidemia #HeartHealth https://t.co/RufGggiOmF

  • Mashup Score: 2

    A dedicated curriculum to educate clinicians on the risks associated with severely elevated triglycerides and the potential role of novel treatments to optimize outcomes in patients with sHTG and FCS.

    Tweet Tweets with this article
    • 🎯 Targeting apoC-III not only lowers TG levels but also enhances the clearance of triglyceride-rich lipoproteins, addressing the root cause of severe hypertriglyceridemia. Learn the latest ➡️ https://t.co/FDJoM5TZXC https://t.co/vdWQX0A5mA